CSTDs are critical to protecting healthcare workers from hazardous drug exposure, which is now legally required in the US under USP800 legislation. Currently, there are no options that meet this legislation for healthcare workers who deliver subcutaneous or intra-muscular injections. The VaporShield provides a true closed system from drug draw to injection and through disposal while retaining the crucial safety syringe features of our Aeroject^™ auto retractable syringe to stop needlestick injuries.

Guy Reynolds, Chief Executive Officer of Zephyrus, said: “VaporShield is a truly game-changing device. The seriously negative health impacts caused by exposure to hazardous drugs are well documented but unfortunately, there has been no device that fully protects healthcare workers giving these drugs via subcutaneous or intra-muscular administration, until now.”